Ocumension Therapeutics HKEX:1477:
NMPA APPROVES OT-502 (DEXYCU) NEW DRUG APPLICATION IN CHINA
Reuters
Ocumension Therapeutics Says NMPA Approves Ot-502 (Dexycu) New Drug Application In China
- Sources
- Reuters
- Markets
- ETFs, Stocks
- Active symbols
- HKEX:1477
- Language
- English
Ocumension Therapeutics HKEX:1477: